ImmunityBio Inc. Common Stock vs PNC Financial Services Group Inc. (The) Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.46 (market cap $10.51B), while PNC Financial Services Group Inc. (The) Common Stock trades at $218.64 (market cap $87.64B). The key difference: PNC Financial Services Group Inc. (The) Common Stock is far larger — about 8.3× ImmunityBio Inc. Common Stock's market cap, and PNC Financial Services Group Inc. (The) Common Stock pays a 3.64% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals.
| IBRX | PNC | |
|---|---|---|
Market Cap | $10.51B | $87.64B |
Volume | 10,445,785 | 1,687,662 |
Sector | Health | Financials |
52-Week High | $11.55 | $256.97 |
52-Week Low | $1.98 | $178.37 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $10.97B | $144.63B |
Dividend Yield | — | 3.64% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →PNC Financial Services Group is a financial services holding company. Its businesses include retail banking, corporate and institutional banking, and asset management.
Read more on PNC →